NEENAH, WI(GLOBE NEWSWIRE) — Plexus Corp. (NASDAQ: PLXS) today announced financial results for our fiscal third quarter ended June 28, 2025, and guidance for our fiscal fourth quarter ending September 27, 2025.
- Reports fiscal third quarter 2025 revenue of $1.018 billion, GAAP operating margin of 5.3% and GAAP diluted EPS of $1.64.
- Reports fiscal third quarter 2025 non-GAAP operating margin of 6.0% and non-GAAP diluted EPS of $1.90, excluding $0.26 of stock-based compensation expense.
- Initiates fiscal fourth quarter 2025 revenue guidance of $1.025 billion to $1.065 billion with GAAP diluted EPS of $1.57 to $1.72, including $0.25 of stock-based compensation expense. Fiscal fourth quarter non-GAAP EPS guidance of $1.82 to $1.97 excludes stock-based compensation expense.
| Three Months Ended | |||||||
| Jun 28, 2025 | Jun 28, 2025 | Sep 27, 2025 | |||||
| Q3F25 Results | Q3F25 Guidance | Q4F25 Guidance | |||||
| Summary GAAP Items | |||||||
| Revenue (in billions) | $1.018 | $1.000 to $1.040 | $1.025 to $1.065 | ||||
| Operating margin | 5.3% | 5.0% to 5.4% | 5.0% to 5.4% | ||||
| Diluted EPS | $1.64 | $1.40 to $1.55 | $1.57 to $1.72 | ||||
| Summary Non-GAAP Items (1) | |||||||
| Adjusted operating margin (2) | 6.0% | 5.7% to 6.1% | 5.7% to 6.1% | ||||
| Adjusted EPS (3) | $1.90 | $1.65 to $1.80 | $1.82 to $1.97 | ||||
| Return on invested capital (ROIC) | 14.1% | ||||||
| Economic return | 5.2% | ||||||
| (1) Refer to Non-GAAP Supplemental Information tables for additional information regarding non-GAAP financial measures. |
|||||||
| (2) Excludes stock-based compensation expense of approximately 70 bps for Q3F25 results, Q3F25 guidance and Q4F25 guidance. |
|||||||
| (3) Excludes stock-based compensation expense, net of tax, of $0.26 for Q3F25 results and $0.25 for Q3F25 guidance and Q4F25 guidance. |
|||||||
Fiscal Third Quarter 2025 Information
- Won 41 manufacturing programs during the quarter representing $250 million in annualized revenue when fully ramped into production.
- Generated fiscal third quarter free cash flow of $13.2 million, contributing to fiscal year-to-date free cash flow of $56.8 million.
- Purchased $18.4 million of our shares at an average price of $128.70 per share during the quarter.
- As previously announced on May 14, 2025, Plexus’ Board of Directors approved a new $100.0 million share repurchase program. Plexus has recently begun repurchasing shares under this $100.0 million program as the previous $50.0 million program has been fulfilled.
Todd Kelsey, President and Chief Executive Officer, commented, “Our Plexus team continues to execute at a high level in driving numerous efficiency initiatives, which resulted in another strong quarter of financial performance. Fiscal third quarter revenue of $1.018 billion grew sequentially and was in-line with guidance, non-GAAP operating margin of 6.0% was near the high end of guidance and non-GAAP EPS of $1.90 exceeded guidance. Furthermore, free cash flow again surpassed our expectations.”
Patrick Jermain, Executive Vice President and Chief Financial Officer, commented, “Fiscal third quarter cash cycle of 69 days was consistent with expectations and one day higher than the fiscal second quarter. For the sixth consecutive quarter, we drove a reduction in our gross inventory balance. This result, combined with other improvements to our cash cycle and our strong operating performance, produced fiscal third quarter return on invested capital of 14.1%, which exceeded our weighted average cost of capital by 520 basis points. We also delivered better than anticipated free cash flow of $13.2 million in support of our expectation to achieve approximately $100 million in free cash flow for fiscal 2025. Finally, furthering our commitment to return cash to our shareholders, we repurchased $18.4 million of our shares during the fiscal third quarter, while adding a $100 million share repurchase program to our previous, now fully-utilized, $50 million program.”
Mr. Kelsey added, “Our go-to-market team secured 41 fiscal third quarter manufacturing wins with well-balanced market sector diversification, representing $250 million in annualized revenue. Included in these wins are share gains resulting from our sustained focus on zero defects and perfect delivery as well as new customers in each of our market sectors with products aligned to exciting growth technologies.”
Mr. Kelsey continued, “We expect to deliver strong fiscal fourth quarter financial results, including further sequential revenue growth. We anticipate generating this revenue expansion through share gains, new program ramps and growth with new customers, while overcoming muted end market demand, evolving new program ramp timelines and uncertainties created by tariffs. We are guiding revenue of $1.025 to $1.065 billion, non-GAAP operating margin of 5.7% to 6.1% and non-GAAP EPS of $1.82 to $1.97. At the midpoint, our fiscal fourth quarter guidance would result in robust non-GAAP fiscal 2025 EPS growth of 26%.”
Mr. Kelsey concluded, “We are committed to creating long-term shareholder value through enabling customer success and focused initiatives that drive organizational and operational efficiency. We are bullish on the growth opportunities our solutions and market sectors provide. Our strategy is creating opportunities to gain share and capture new outsourcing opportunities in support of delivering sustained strong financial performance and growth exceeding that of our end markets.”
| Quarterly Comparison | Three Months Ended | ||||||||||
| (in thousands, except EPS) | Jun 28, 2025 | Mar 29, 2025 | Jun 29, 2024 | ||||||||
| Revenue | $ | 1,018,308 | $ | 980,170 | $ | 960,751 | |||||
| Gross profit | 103,288 | 97,751 | 94,415 | ||||||||
| Operating income | 53,608 | 48,791 | 39,246 | ||||||||
| Net income | 45,116 | 39,073 | 25,140 | ||||||||
| Diluted EPS | $ | 1.64 | $ | 1.41 | $ | 0.91 | |||||
| Gross margin | 10.1 | % | 10.0 | % | 9.8 | % | |||||
| Operating margin | 5.3 | % | 5.0 | % | 4.1 | % | |||||
| ROIC (1) | 14.1 | % | 13.7 | % | 10.4 | % | |||||
| Economic return (1) | 5.2 | % | 4.8 | % | 2.2 | % | |||||
| (1) Refer to Non-GAAP Supplemental Information tables for non-GAAP financial measures discussed and/or disclosed in this release, such as adjusted operating margin, adjusted net income, adjusted diluted EPS, ROIC and economic return. | |||||||||||
Business Segment and Market Sector Revenue
Plexus measures operational performance and allocates resources on a geographic segment basis. Plexus also reports revenue based on the market sector breakout set forth in the table below, which reflects Plexus’ market sector focused strategy. Top 10 customers comprised 48% of revenue during the third quarter of both fiscal 2025 and 2024, which is down three percentage points from the second quarter of fiscal 2025.
| Business Segments ($ in millions) | Three Months Ended | |||||||||||
| Jun 28, 2025 | Mar 29, 2025 | Jun 29, 2024 | ||||||||||
| Americas | $ | 312 | $ | 295 | $ | 306 | ||||||
| Asia-Pacific | 594 | 587 | 521 | |||||||||
| Europe, Middle East and Africa | 117 | 103 | 137 | |||||||||
| Elimination of inter-segment sales | (5 | ) | (5 | ) | (3 | ) | ||||||
| Total Revenue | $ | 1,018 | $ | 980 | $ | 961 | ||||||
| Market Sectors ($ in millions) | Three Months Ended | |||||||||||||
| Jun 28, 2025 | Mar 29, 2025 | Jun 29, 2024 | ||||||||||||
| Aerospace/Defense | $ | 183 | 18 | % | $ | 172 | 18 | % | $ | 178 | 18 | % | ||
| Healthcare/Life Sciences | 420 | 41 | % | 411 | 42 | % | 380 | 40 | % | |||||
| Industrial | 415 | 41 | % | 397 | 40 | % | 403 | 42 | % | |||||
| Total Revenue | $ | 1,018 | $ | 980 | $ | 961 | ||||||||
Non-GAAP Supplemental Information
Plexus provides non-GAAP supplemental information, such as ROIC, economic return and free cash flow, because such measures are used for internal management goals and decision-making, and because they provide management and investors with additional insight into financial performance. In addition, management uses these and other non-GAAP measures, such as adjusted operating income, adjusted operating margin, adjusted net income and adjusted diluted EPS, to provide a better understanding of core performance for purposes of period-to-period comparisons. Plexus believes that these measures are also useful to investors because they provide further insight by eliminating the effect of non-recurring items that are not reflective of continuing operations. For additional information on non-GAAP measures, please refer to the attached Non-GAAP Supplemental Information tables.
ROIC and Economic Return
ROIC for the third quarter of fiscal 2025 was 14.1%. Plexus defines ROIC as tax-effected annualized adjusted operating income divided by average invested capital over a four-quarter period for the third fiscal quarter. Invested capital is defined as equity plus debt and operating lease obligations, less cash and cash equivalents. Plexus’ weighted average cost of capital for fiscal 2025 is 8.9%. ROIC for the third quarter of fiscal 2025 less Plexus’ weighted average cost of capital resulted in an economic return of 5.2%.
Free Cash Flow
Plexus defines free cash flow as cash flows provided by operations less capital expenditures. For the three months ended June 28, 2025, cash flows provided by operations was $26.9 million, less capital expenditures of $13.7 million, resulting in free cash flow of $13.2 million.
| Cash Cycle Days | Three Months Ended | ||||||
| Jun 28, 2025 | Mar 29, 2025 | Jun 29, 2024 | |||||
| Days in Accounts Receivable | 59 | 57 | 61 | ||||
| Days in Contract Assets | 13 | 12 | 11 | ||||
| Days in Inventory | 128 | 132 | 151 | ||||
| Days in Accounts Payable | (72) | (70) | (62) | ||||
| Days in Advanced Payments | (59) | (63) | (78) | ||||
| Annualized Cash Cycle (1) | 69 | 68 | 83 | ||||
| (1) Plexus calculates cash cycle as the sum of days in accounts receivable, days in contract assets and days in inventory, less days in accounts payable and days in advanced payments. |
|||||||










